RedBrick AI
AI NativeRapid & Collaborative Medical Data Annotation
Est 2020|Raised $5.1M
Published Jul 14, 2026
No credible public market share datasets specific to the radiology annotation subcategory were found in the reviewed sources.
| Starting Price | Quote-based (not publicly listed) | Usage-based + plan tiers; vendor documentation details consumption metrics | Generally quote-based / tiered (varies by product; verify) |
| Primary Use Case | Radiology-focused DICOM viewing, volumetric segmentation, and clinical validation workflows | Broad enterprise labeling across modalities, workforce and governance features | General-purpose visual data tooling and automation; may require adaptation for DICOM workflows |
| Key Strength | Radiology-native viewer and volumetric segmentation workflows; external storage integration options | Enterprise governance, broad modality support, ecosystem integrations | Flexible CV tooling and automation; wide modality support |
| Key Weakness | Limited independent review footprint; pricing transparency limited; brand-name collisions complicate review discovery | Billing complexity and add-on costs; may be heavyweight for small teams | May require customization for radiology-native DICOM workflows |
—